Net profit of Mankind Pharma declined 10.71% to Rs 420.77 crore in the quarter ended March 2025 as against Rs 471.24 crore during the previous quarter ended March 2024. Sales rose 27.13% to Rs 3079.37 crore in the quarter ended March 2025 as against Rs 2422.24 crore during the previous quarter ended March 2024.
For the full year,net profit rose 4.08% to Rs 1990.96 crore in the year ended March 2025 as against Rs 1912.90 crore during the previous year ended March 2024. Sales rose 18.98% to Rs 12207.44 crore in the year ended March 2025 as against Rs 10260.44 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 3079.37 | 2422.24 | 27 | 12207.44 | 10260.44 | 19 |
| OPM % | 22.19 | 24.20 | - | 24.72 | 24.50 | - |
| PBDT | 746.30 | 671.69 | 11 | 3137.55 | 2776.36 | 13 |
| PBT | 515.43 | 571.91 | -10 | 2516.33 | 2397.94 | 5 |
| NP | 420.77 | 471.24 | -11 | 1990.96 | 1912.90 | 4 |